Discussion Post: Non-Pharmacological Management of Hypertension
o Who will benefit from receipt of this evidence?
o Where will this evidence have the greatest impact?
o What resources are needed?
o Who is the most appropriate audience?
o What are the benefits of this evidence to your selected audience?
o What are the potential risks of failing to disseminate this evidence?
o What are the barriers to dissemination of evidence?
The response must include a reference list. Using Times New Roman 12 pnt font, double-space, one-inch margins, and APA style of writing and citations.
References
Kario, K., Chia, Y. C., Sukonthasarn, A., Turana, Y., Shin, J., Chen, C. H., ... & Wang, J. G. (2020). Diversity of and initiatives for hypertension management in Asia-Why we need the HOPE Asia Network. The Journal of Clinical Hypertension, 22(3), 331-343.